Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma.
about
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trialIntra- and Extra-Cellular Events Related to Altered Glycosylation of MUC1 Promote Chronic Inflammation, Tumor Progression, Invasion, and MetastasisOver-expression of ST3Gal-I promotes mammary tumorigenesis.Comparison between colorectal low- and high-grade mucinous adenocarcinoma with MUC1 and MUC5AC.Complex of MUC1, CIN85 and Cbl in Colon Cancer Progression and Metastasis.Characterization of cancer associated mucin type O-glycans using the exchange sialylation properties of mammalian sialyltransferase ST3Gal-II.MUC1-C activates the TAK1 inflammatory pathway in colon cancerPrognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration.Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool.Clinicopathological utility of sialoglycoconjugates in diagnosing and treating colorectal cancer.Restoring anti-oncodriver Th1 responses with dendritic cell vaccines in HER2/neu-positive breast cancer: progress and potential.
P2860
Q21261279-603C90E6-5DC6-4D16-8C1E-D27DF7949284Q28066445-988E0979-EFFA-4930-A468-C6DEF3690536Q34107518-B04CDC3E-585D-4BF8-94C5-83F712EE51A3Q34390848-BE823DE9-FD82-47A2-BA98-D3A06BF71AFCQ35237521-DF4072CE-EFAA-4949-9FE8-B308BDD7178BQ35874802-FAC6F385-8367-4790-BDDE-D4261DC0DB24Q35931767-60E25645-2AB7-49CA-BA4C-E13E93C0646BQ36014430-8D25FD97-EF83-48F9-B2DC-F4214E0F9BE3Q37381597-B1D54190-821A-49E0-81FD-B41526CD77DCQ37860943-0E925F12-0B43-4698-B0DE-6A0DCEC23F50Q38216010-995CFE83-1283-4057-A37E-5046EB271989Q38948901-14FF32BE-273D-4EFC-81C7-3422D3297BBA
P2860
Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Expression of MUC1 recognized ...... s of advanced colon carcinoma.
@en
type
label
Expression of MUC1 recognized ...... s of advanced colon carcinoma.
@en
prefLabel
Expression of MUC1 recognized ...... s of advanced colon carcinoma.
@en
P2093
P1476
Expression of MUC1 recognized ...... s of advanced colon carcinoma.
@en
P2093
Akinori Yanaka
Akira Nakahara
Eiji Shinozaki
Hideo Suzuki
Junichi Shoda
Naoki Miyahara
Naomi Tanaka
Souichi Hotta
Tatsuro Irimura
Toru Kawamoto
P304
P356
10.1023/B:CLIN.0000046133.35133.CC
P577
2004-01-01T00:00:00Z
P6179
1049848433